Vyvgart Hytrulo efgartigimod alfa 1,008 mg and hyaluronidase 11,200 units per 5.6 mL (180 mg/2,000 units per mL) single-dose vial Images
Generic Name: efgartigimod alfa/hyaluronidase
This medication has been identified as Vyvgart Hytrulo efgartigimod alfa 1,008 mg and hyaluronidase 11,200 units per 5.6 mL (180 mg/2,000 units per mL) single-dose vial. It is supplied by argenx US, Inc.
Vyvgart Hytrulo is used in the treatment of Myasthenia Gravis and belongs to the drug class immune globulins. Vyvgart Hytrulo efgartigimod alfa 1,008 mg and hyaluronidase 11,200 units per 5.6 mL (180 mg/2,000 units per mL) single-dose vial is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Vyvgart Hytrulo
- Generic Name
- efgartigimod alfa/hyaluronidase
- Strength
- efgartigimod alfa 1,008 mg and hyaluronidase 11,200 units per 5.6 mL (180 mg/2,000 units per mL) single-dose vial
- Availability
- Prescription only
- Drug Class
- Immune globulins
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- argenx US, Inc.
- Manufacturer
- Halozyme Therapeutics, Inc.
- National Drug Code (NDC)
- 73475-3102
More about Vyvgart Hytrulo (efgartigimod alfa / hyaluronidase)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: immune globulins
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
